Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Thymalin

Thymulin, Thymic Factor, Serum Thymic Factor, Facteur Thymique Serique

Quick Stats
Studies 202
Trials 37
Score 2
1989 pubmed

[Effect of thymalin on the immunological indices and morphofunctional structure of the uterus in guinea pigs with endometrial hyperplasia].

Zaporozhan. V N VN; Khait. O V OV; Li. L N LN

Key Findings

  • Synthetic estrogen (synestrol) caused endometrial hyperplasia and reduced T‑ and B‑lymphocytes in guinea pigs
  • Thymalin treatment normalized immune system indices
  • Thymalin partially restored normal uterine morphology

Practical Outcomes

  • The results suggest thymalin might have immune‑supporting and tissue‑repair properties, but the evidence is limited to an animal model of uterine overgrowth. For biohackers, it’s a preliminary hint rather than a ready‑to‑use protocol; more human research is needed before recommending dosage or routine use.

Summary

In a study on guinea pigs, a synthetic estrogen caused the lining of the uterus to overgrow and lowered immune cells. Giving the peptide thymalin helped bring immune cell numbers back toward normal and partially fixed the uterine tissue changes. This shows thymalin can modulate immunity and tissue health in this animal model, but it’s far from proven in humans.

Abstract

The efficiency of usage of the preparations of thymalin in hyperplasia of endometrium has been studied in the experiment on 125 female guinea pigs. Indicated pathology was caused by the introduction of oil solution of synestrol during 19 weeks. It is determined that marked hyperplasia of endometrium is developing as a result of prolonged introduction of synestrol in experimental animals and the decrease of the amount of T- and B-lymphocytes takes place. The use of thymalin results in normalization of indexes of immune system and in partial normalization of morphologic structure of endometrium.

Study Information

Provider

pubmed

Year

1989